Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

2,130.00p
   
  • Change Today:
    -18.00p
  • 52 Week High: 2,340.00
  • 52 Week Low: 1,772.00
  • Currency: UK Pounds
  • Shares Issued: 234.72m
  • Volume: 105,044
  • Market Cap: £4,999.53m
  • RiskGrade: 125

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 2.8% 0.0%
Div Cover 2.8 2.8
Op Mrgn 19.6% 22.3%
ROCE 24.3%  
Latest F'cast
P/E 13.0 12.5
PEG 28.9 3.9
Pr/Revenue 2.2 1.5
Pr/Book 2.9  
Latest F'cast
Revenue 8.8% -21.7%
PBT 61.9% 19.8%
EPS 0.4% 3.2%
DPS 11.1% -42.8%

HIK Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 2,341.00 558.00 172.90¢ 19.7 1.3 +15% 50.00¢ 1.5%
31-Dec-21 2,553.00 544.00 194.80¢ 15.4 1.2 +13% 54.00¢ 1.8%
31-Dec-22 2,517.00 233.00 181.00¢ 11.6 n/a -7% 56.00¢ 2.7%
31-Dec-23 2,875.00 281.00 223.00¢ 10.8 0.5 +23% 72.00¢ 3.0%
31-Dec-24 3,127.00 455.00 224.00¢ 12.0 n/a 0% 80.00¢ 3.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

HIK Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 3,306.06 735.66 171.67p 12.5 3.9 +3% 61.83p 0.0%
31-Dec-26 3,463.32 790.81 187.95p 11.4 1.2 +10% 66.79p 0.0%
31-Dec-27 3,667.22 849.34 206.55p 10.4 1.1 +10% 72.47p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

HIK Company Announcements

Director/PDMR Shareholding 03-Jun-2025 13:02 RNS
Fitch upgrades Hikma to ‘BBB’ 29-May-2025 07:00 RNS
Director/PDMR Shareholding 20-May-2025 14:49 RNS

HIK ShareCast News

Broker tips: Kingfisher, Accesso, Hikma 20-May-2025 ShareCast
RBC Capital ups price target on Hikma 20-May-2025 ShareCast
Hikma surges as investors welcome medium-term gu... 15-May-2025 ShareCast

HIK Top Newspaper Links

Hikma boosts injectables business with $300m deal 29-May-2014 Telegraph
MARKET REPORT: Shares jump as Hikma Pharmaceutic... 08-May-2014 Daily Mail
Hikma prepares return to Libya 26-Aug-2011 The Independent

Latest HIK Director Deals

Traded Action Notifier PriceAmountValue
30-May-25 Transfer From Mazen Darwazah 0.000p 36,171 £0.00
30-May-25 Sell Said Darwazah 2,138.00p 13,863 £296,390.93
30-May-25 Transfer From Riad Mishlawi 0.000p 36,371 £0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

HIK Market Data

Currency UK Pounds
Share Price 2,130.00p
Change Today -18.00p
% Change -0.84 %
52 Week High 2,340.00
52 Week Low 1,772.00
Volume 105,044
Shares Issued 234.72m
Market Cap £4,999.53m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.34% below the market average91.34% below the market average91.34% below the market average91.34% below the market average91.34% below the market average
47.83% below the sector average47.83% below the sector average47.83% below the sector average47.83% below the sector average47.83% below the sector average
Price Trend
65.66% above the market average65.66% above the market average65.66% above the market average65.66% above the market average65.66% above the market average
69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average
Income
2.46% below the market average2.46% below the market average2.46% below the market average2.46% below the market average2.46% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
30.87% above the market average30.87% above the market average30.87% above the market average30.87% above the market average30.87% above the market average
26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 2
Sell 0
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 20-Mar-25 15-Aug-24
Paid 01-May-25 20-Sep-24
Amount 48.00¢ 32.00¢

Trades for 03-Jun-2025

Time Volume / Share Price
13:32 61 @ 2,130.00p
13:32 106 @ 2,130.00p
13:32 47 @ 2,130.00p
13:31 250 @ 2,129.48p
13:24 15 @ 2,130.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page